(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

KALA HEALTH

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

KALA HEALTH

ST13

US500000088125168

Class

5

Filing

88125168

Registration

5941338

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

06/24/2026

Trademark type

Combined

Nice classes

5

Filing date

09/20/2018

Registration date

12/24/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/24/2019

Last transaction

06/24/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

01/02/1997

First use in commerce

01/02/1997

Drawing code

3

Owner type

03

Owner location

MERIDEN, CT, US

Examiner

WILKE, JOHN

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the words "Kala health" in stylized white font underlined with a curved red line, all inside a blue rectangular banner with curved borders of green, purple, yellow and orange.

Holders and representatives

Holders

KALA HEALTH ENRICHMENT, INC.
Kala Health Enrichment, Inc

Representatives

Michelle A. Arace The Law Firm of Michelle A. Arace

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Nutritional and dietary supplements for humans and animalsexcluding pharmaceutical preparations for use in the treatment of ophthalmological diseases and inflammatory diseases; and drug delivery agents in the form of a coating for active ingredients of a pharmaceutical to facilitate the delivery of a wide range of pharmaceuticals

Publications

History of USPTO decisions and trademark events.

31 publications found

E815

TEAS SECTION 8 & 15 RECEIVED

06/23/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/24/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

12/24/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/08/2019

PUBO

PUBLISHED FOR OPPOSITION

10/08/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/18/2019

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

09/11/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/05/2019

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

08/15/2019

GNSL

LETTER OF SUSPENSION E-MAILED

08/15/2019

CNSL

SUSPENSION LETTER WRITTEN

08/15/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/07/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/07/2019

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

08/06/2019

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

08/06/2019

GPRA

PRIORITY ACTION E-MAILED

08/06/2019

CPRA

PRIORITY ACTION WRITTEN

08/06/2019

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

07/10/2019

GNSL

LETTER OF SUSPENSION E-MAILED

07/10/2019

CNSL

SUSPENSION LETTER WRITTEN

07/10/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/10/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/10/2019

ALIE

ASSIGNED TO LIE

07/10/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/03/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/03/2019

GNRT

NON-FINAL ACTION E-MAILED

01/03/2019

CNRT

NON-FINAL ACTION WRITTEN

01/03/2019

DOCK

ASSIGNED TO EXAMINER

01/02/2019

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/27/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/26/2018

NWAP

NEW APPLICATION ENTERED

09/24/2018

Continuous trademark protection

Get notified about every new filing that threatens KALA HEALTH or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.